Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus ointment vs topical silicone gel for scar prevention after median sternotomy
TCTR20220602004Phase 3Unknown
- Sponsor
- N/A
- Start
- Feb 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in Hypertrophic Scar (HS), keloid, sponsored by N/A. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on TCTR20220602004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220602004.